Intravitreal and subtenon depot triamcinolone as treatment of retinitis pigmentosa associated cystoid macular edema
- PMID: 24455364
- PMCID: PMC3885263
- DOI: 10.1155/2013/591681
Intravitreal and subtenon depot triamcinolone as treatment of retinitis pigmentosa associated cystoid macular edema
Abstract
We present a case of retinitis pigmentosa (RP) related cystoid macular edema (CME) refractory to oral acetazolamide and topical ketorolac that was treated with intravitreal and subtenon depot triamcinolone. A 32-year-old male with RP presented with complaints of bilateral decrease in visual acuity. His best-corrected visual acuity (BCVA) was 20/50 in the right eye and 20/100 in the left eye. After being informed of the available treatment options, the patient received bilateral intravitreal injection triamcinolone. The patient's BCVA improved to 20/40 in the right eye and 20/50 in the left eye and the CME was resorbed. However, 5 months after the injection in the left eye and two months in the right eye, visual acuity decreased due to recurrence of CME. We performed a second intravitreal injection in the left eye with improvement of visual and anatomic results, but we observed a recurrence of CME. Afterwards, we treated the patient with subtenon depot triamcinolone in both eyes, with the result that there was no recurrence after 4 months in OD or after 3 months in OS. We conclude that intravitreal and subtenon depot triamcinolone appear to provide at least temporary benefit in refractory CME as regards the improvement of visual acuity.
Figures










Similar articles
-
Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide.Ophthalmic Surg Lasers Imaging. 2003 Sep-Oct;34(5):398-400. Ophthalmic Surg Lasers Imaging. 2003. PMID: 14509465
-
Short-term outcomes of subtenon triamcinolone acetonide injections in patients with retinitis pigmentosa-associated cystoid macular edema unresponsive to carbonic anhydrase inhibitors.Int Ophthalmol. 2020 Mar;40(3):677-687. doi: 10.1007/s10792-019-01228-z. Epub 2019 Nov 26. Int Ophthalmol. 2020. PMID: 31773389
-
Intravitreal pegaptanib sodium (Macugen) for refractory cystoid macular edema in pericentral retinitis pigmentosa.Int Ophthalmol. 2009 Apr;29(2):103-7. doi: 10.1007/s10792-007-9175-1. Epub 2007 Dec 22. Int Ophthalmol. 2009. PMID: 18157710
-
Intravitreal aflibercept (Eylea) injection for cystoid macular edema secondary to retinitis pigmentosa - a first case report and short review of the literature.BMC Ophthalmol. 2015 Apr 30;15:44. doi: 10.1186/s12886-015-0033-z. BMC Ophthalmol. 2015. PMID: 25925748 Free PMC article. Review.
-
The effect of an intravitreal dexamethasone implant for cystoid macular edema in retinitis pigmentosa: a case report and literature review.Ophthalmic Surg Lasers Imaging Retina. 2014 Mar-Apr;45(2):160-4. doi: 10.3928/23258160-20140131-03. Epub 2014 Feb 7. Ophthalmic Surg Lasers Imaging Retina. 2014. PMID: 24506098 Review.
Cited by
-
Efficacy of additional topical betamethasone in persistent cystoid macular oedema after carbonic anhydrase inhibitor treatments in retinitis pigmentosa.BMJ Open Ophthalmol. 2018 Jan 28;3(1):e000107. doi: 10.1136/bmjophth-2017-000107. eCollection 2018. BMJ Open Ophthalmol. 2018. PMID: 29657976 Free PMC article.
-
The effects of VEGF-A-inhibitors aflibercept and ranibizumab on the ciliary body and iris of monkeys.Graefes Arch Clin Exp Ophthalmol. 2016 Jun;254(6):1117-25. doi: 10.1007/s00417-016-3344-8. Epub 2016 Apr 22. Graefes Arch Clin Exp Ophthalmol. 2016. PMID: 27106625
-
Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of intervention.Br J Ophthalmol. 2017 Jan;101(1):31-37. doi: 10.1136/bjophthalmol-2016-309376. Epub 2016 Dec 2. Br J Ophthalmol. 2017. PMID: 27913439 Free PMC article. Review.
-
Treatment of Retinitis Pigmentosa-Associated Cystoid Macular Oedema Using Intravitreal Aflibercept (Eylea) despite Minimal Response to Ranibizumab (Lucentis): A Case Report.Case Rep Ophthalmol. 2016 Sep 7;7(2):389-397. doi: 10.1159/000448427. eCollection 2016 May-Aug. Case Rep Ophthalmol. 2016. PMID: 27721789 Free PMC article.
References
-
- Marmor MF, Aguirre G, Arden G. Retinitis pigmentosa. A symposium on terminology and methods of examination. Ophthalmology. 1983;90(2):126–131. - PubMed
-
- Ozdemir H, Karacorlu M, Karacorlu S. Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa. Acta Ophthalmologica Scandinavica. 2005;83(2):248–251. - PubMed
-
- Fishman GA, Glenn AM, Gilbert LD. Rebound of macular edema with continued use of methazolamide in patients with retinitis pigmentosa. Archives of Ophthalmology. 1993;111(12):1640–1646. - PubMed
-
- Fishman GA, Maggiano JM, Fishman M. Foveal lesions seen in retinitis pigmentosa. Archives of Ophthalmology. 1977;95(11):1993–1996. - PubMed
-
- Moldow B, Sander B, Larsen M, et al. The effect of acetazolamide on passive and active transport of fluorescein across the blood-retina barrier in retinitis pigmentosa complicated by macular oedema. Graefe’s Archive for Clinical and Experimental Ophthalmology. 1998;236(12):881–889. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources